Overview
Vilon is “a synthetic immunoregulatory dipeptide consisting of lysine and glutamic acid residues.” Research indicates it may enhance immune markers including CD5+ lymphocytes and interleukin-2 expression in cell cultures.
Quick Start
– Reconstitution: Add 3.0 mL bacteriostatic water to create approximately 6.67 mg/mL concentration
– Dosing Range: 67–670 mcg once daily
– Schedule: 5 consecutive days per 4-week cycle
– Measurement: At standard concentration, 1 unit on insulin syringe ≈ 66.7 mcg
– Storage (Lyophilized): −20 °C (−4 °F) short-term; refrigerate reconstituted vials at 2–8 °C
Standard Dosing Protocol
Pulsed Titration Approach (First Cycle):
| Day | Dose | Units |
|---|---|---|
| 1 | 67 mcg | 1 unit |
| 2 | 133 mcg | 2 units |
| 3 | 200 mcg | 3 units |
| 4 | 267 mcg | 4 units |
| 5 | 333 mcg | 5 units |
Subsequent Cycles: 333–667 mcg (5–10 units) daily for 5 days, then 23 days rest. Repeat for 2–4 cycles total.
Reconstitution Steps
1. Draw 3.0 mL bacteriostatic water with sterile syringe
2. Inject slowly along vial wall; avoid foaming
3. Gently swirl until dissolved (do not shake)
4. Label and refrigerate at 2–8 °C; use within ~1 week or freeze aliquots
Administration Guidelines
– Route: Subcutaneous injection
– Frequency: Once daily during 5-day active phase
– Injection Angle: 45–90° into subcutaneous tissue
– Site Rotation: Abdomen, thighs, upper arms to prevent irritation
– Timing: No aspiration needed; inject slowly and steadily
– Syringes: 30- or 50-unit insulin syringes recommended for accuracy
How It Works
Vilon belongs to “short bioregulatory peptides developed through Russian gerontology research.” In vitro studies demonstrate the dipeptide modulates lymphocyte populations and cytokine gene expression, particularly increasing CD5+ cells in thymus cultures and upregulating interleukin-2 mRNA in splenocytes.
Potential Benefits
– Supports immune cell marker expression (CD5+ lymphocytes) and IL-2 activity in cell models
– May modulate inflammatory cytokines like TGF-β1 under experimental conditions
– Early mouse studies suggest potential effects on tumor inhibition, though human data remain limited
Side Effects & Considerations
– Generally well tolerated in preclinical settings
– Occasional mild injection-site reactions (redness/itching) may occur
– No serious adverse events reported in available research
Lifestyle Support
– Nutrient-dense diet rich in antioxidants and adequate protein
– Regular moderate exercise
– 7–9 hours sleep nightly
– Stress management techniques
Storage Instructions
Lyophilized: Store at −20 °C short-term or −80 °C long-term in dry, dark conditions
Reconstituted: Refrigerate at 2–8 °C; use within approximately 1 week or prepare aliquots and freeze
Allow vials to reach room temperature before opening to minimize condensation.
Important Notes
– Use new sterile syringes; dispose in sharps container
– Document daily doses and site rotations
– Rotate injection sites systematically
– “This educational protocol presents a pulsed subcutaneous approach (5 consecutive days per 4-week cycle)”
– For research use only; not for human consumption
Supplies Needed (Per Protocol Duration)
– Peptide Vials: ~1 vial per 8–16 weeks
– Insulin Syringes: 5 per cycle (U-100, 30- or 50-unit)
– Bacteriostatic Water: 3 mL per vial
– Alcohol Swabs: 10 per cycle
Disclaimer: This content is for educational purposes only and does not constitute medical advice. For research use only. Always consult qualified healthcare professionals before beginning any protocol.